News & Analysis on Clinical Trial Services & Contract Research And Development
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Novartis’ former CEO joining Amylin’s board and an appointment at OctoPlus.
US CDMO Cook Pharmacia has won the contract to make the API for BiioLex’s candidate extended-release antiviral Locteron.
Neuland Laboratories is building a facility to produce HPAPIs, which it predicts will contribute 20 per cent of its bottom line over the next two to three years, and has begun commercial peptide manufacture.
Chemicals firm Durect will supply drugmaker King Pharmaceuticals with two excipients used in the manufacture of the candidate anti-abuse painkiller Remoxy in an agreement signed last week.
Demand for Cerep’s pharmacological profiling services picked up in the second quarter and it believes this, coupled to cost savings and commencement of delayed contracts, will help it improve in the second half of 2009.
Basel-headquartered Roche has paid fellow Swiss firm Lonza $290m (€203m) for its Singapore biologics plant in a bid to secure long-term manufacturing capacity for biotech cancer drugs.